Top Markets
#1 ADO Protocol ADO Protocol +193.34%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +44.27%
#4 GAIB AID GAIB AID +24.67%
#5 SkyAI SkyAI +14.39%
#6 Verus Coin Verus Coin +13.64%
#7 o1.exchange o1.exchange +12.48%
#8 Tutorial Tutorial +12.27%
#9 Casper Network Casper Network +12.23%
#10 Pons Pons +12.22%
Coin of the day
ADO Protocol ADO Protocol
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Pozycja w akcjach #33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Cena akcji
$0.5099
Ostatnia synchronizacja: 2024-10-15
Kapitalizacja rynkowa
$7.60M
Zmiana (1 dzień)
2.02%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Anew Medical, Inc. (WENA)

Kategoria

Healthcare
Zyski dla Anew Medical, Inc. (WENA)
Zyski w Jun 2024 TTM: $114.12K
Według najnowszych raportów finansowych Anew Medical, Inc., obecny zysk firmy wynosi $114.12K. W roku 2022 firma osiągnęła zysk w wysokości $1.56M, wzrost w porównaniu do zysku z roku 2021, który wynosił $-1.11M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Anew Medical, Inc. od 2021 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $114.12K -94.40%
2023 $2.04M 30.95%
2022 $1.56M -240.25%
2021 $-1.11M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B 4,622,261.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B 1,709,242.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B 2,633,790.84%
BE